Collectively, our study revealed a new mechanism underlying SFA’s insulin-sensitizing properties and suggested that therapeutically targeting ceramide synthesis through inhibiting SPTLC3 might be an effective therapeutic for insulin resistance. The gene discussed is INS; the disease is Insulin resistance.